Mild metabolic profile may mask MASLD risk - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Mild metabolic profile may mask MASLD risk

  • By

  • Andrea Surnit

  • September 10, 2026

  • 4 min

Share

Clinical Scorecard: Mild metabolic profile may mask MASLD risk

At a Glance

CategoryDetail
ConditionMetabolic dysfunction-associated steatotic liver disease (MASLD)
Key MechanismsDistinct genetic profiles and disease trajectories among subgroups
Target PopulationPatients with MASLD
Care SettingClinical research and genetic analysis

Key Highlights

  • Five reproducible subgroups of MASLD identified with distinct characteristics
  • Polygenic subgroup (C4) shows mild metabolic profile but significant liver risk
  • C2 and C3 exhibit heterogeneous metabolic profiles
  • C5 has elevated long-term risks of fibrosis and cirrhosis
  • Integration of clinical and genetic data may enhance MASLD management

Guideline-Based Recommendations

Diagnosis

  • Utilize latent class analysis of clinical and demographic variables for subgroup classification

Management

  • Individualized clinical management based on genetic and metabolic risk profiles

Monitoring & Follow-up

  • Longitudinal monitoring of liver-related outcomes in MASLD patients

Risks

  • Increased likelihood of liver transplantation in polygenic subgroup C4

Patient & Prescribing Data

Patients with metabolic dysfunction-associated steatotic liver disease (MASLD)

Subgroup C4 has low incidence of metabolic comorbidities but high liver-specific risks

Clinical Best Practices

  • Consider genetic risk factors in the management of MASLD
  • Monitor for liver complications in patients with mild metabolic profiles

Related Resources & Content

Original Source(s)

Related Content